Evaluating the prognosis of hospitalized patients with liver cirrhosis
Natural Course and Prognosis of Hospitalized Patients With Cirrhosis: a Prospective, Multicenter, and Observational Study
This study is trying to gather information about hospitalized patients with liver cirrhosis to see how their condition changes over time and what factors might affect their health.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 336 (estimated) |
| Ages | 20 Years and up |
| Sex | All |
| Sponsor | Kangbuk Samsung Hospital Academic / other |
| Locations | 4 sites (Hwaseong-si and 3 other locations) |
| Trial ID | NCT05185154 on ClinicalTrials.gov |
What this trial studies
This prospective observational study aims to gather data on hospitalized patients suffering from liver cirrhosis across four institutions in Korea. Participants will have their demographic and clinical information collected, including details on their nutritional status, medication history, and various laboratory and imaging findings. The research database will be updated every six months to track disease outcomes and follow-up care for these patients. This comprehensive data collection will help in understanding the natural progression and prognosis of liver cirrhosis in hospitalized patients.
Who should consider this trial
Good fit: Ideal candidates for this study are hospitalized patients diagnosed with liver cirrhosis who are experiencing complications related to their condition.
Not a fit: Patients admitted to the hospital without cirrhotic complications or those who refuse follow-up care may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the prognosis of liver cirrhosis, potentially leading to improved management strategies for affected patients.
How similar studies have performed: While this study focuses on the natural course of liver cirrhosis, similar observational studies have provided valuable insights into chronic liver diseases, suggesting potential for meaningful findings.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Hospitalized patients with liver cirrhosis * Admission to the hospital because of cirrhotic complications such as uncontrolled ascites, variceal bleeding, hepatic encephalopathy, hepatorenal syndrome, spontaneous bacterial peritonitis, hepatocellular carcinoma, acute kidney injury, bacterial infection, acute liver failure, and etc. Exclusion Criteria: * Admission to the hospital without cirrhotic complications * Patients who refuse the follow-up of outpatient department
Where this trial is running
Hwaseong-si and 3 other locations
- Hallym University Dongtan Sacred Heart Hospital — Hwaseong-si, Korea, Republic of (Recruiting)
- Chosun University Hospital — Kwangju, Korea, Republic of (Recruiting)
- Jae Yoon Jeong — Seoul, Korea, Republic of (Not_yet_recruiting)
- Kangbuk Samsung Hospital — Seoul, Korea, Republic of (Not_yet_recruiting)
Study contacts
- Principal investigator: Won Sohn, MD, PhD — Kangbuk Samsung Hospital
- Study coordinator: Won Sohn, MD, PhD
- Email: hand0827@naver.com
- Phone: 82-2-2001-2557
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.